Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Baxter
Express Scripts
Mallinckrodt
Colorcon

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for Novo Nordisk Inc. v. Lupin Ltd. (S.D.N.Y. 2010)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Novo Nordisk Inc. v. Lupin Ltd. (S.D.N.Y. 2010)

Docket   Start Trial Date Filed 2010-05-06
Court District Court, S.D. New York Date Terminated 2013-12-10
Cause 35:145 Patent Infringement Assigned To Paul G. Gardephe
Jury Demand Defendant Referred To
Parties LUPIN LTD.; NOVO NORDISK A/S; NOVO NORDISK INC.
Patents 6,677,358
Attorneys Aric Hugo Wu; Barry S. White; John Gregory Taylor; Josh Andrew Krevitt; Michael A. Sitzman; Paul John Molino; Rachel Pernic Waldron; Steven M. Amundson; Tara M Raghavan; Wayne M. Barsky; William Andrew Rakoczy
Firms Gibson, Dunn & Crutcher, LLP (CA); Gibson, Dunn & Crutcher, LLP (LA); Gibson, Dunn & Crutcher, LLP (NY)
Link to Docket External link to docket
Small Molecule Drugs cited in Novo Nordisk Inc. v. Lupin Ltd.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Novo Nordisk Inc. v. Lupin Ltd. (S.D.N.Y. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-05-06 1 Complaint infringement of United States Patent No. 6,677,358 pursuant to the patent laws of the United States, 35…2004, United States Patent No. 6,677,358, entitled “NIDDl\/I Regimen,” (the “’358 patent”) was duly and legally…tillll\iil 11 11 U 67 (10) Patent No.: (45) Date of Patent: US 6,677,358 Bl Jan. 13, 2004 (54) Nn…companies. Count 1: Infringement of U.S. Patent No. 6,677,358 16. Novo Nordisk hereby realleges and incorporates…05/06/10 Page 11 of 19 U.S. Patent Jan. 13, 2004 sheet 1 0f4 US 6,677,358 Bl A verage BG pro files External link to document
2010-07-22 25 Answer to Complaint infringement of United States Patent No. 6,677,358 pursuant to the patent laws of the United States, 35…allege infringement of United States Patent No. 6,677,358 (“the ‘358 patent”). Lupin denies all remaining …2004, United States Patent No. 6,677,358, entitled “NIDDM Regimen,” (“the ‘358 patent”) was duly and legally…Trademark Office issued U.S, Patent No. 6,677,358 (“the ‘358 patent”), entitled “NIDDM Regimen,” to Peter Giiartz…Page 6 of 14 COUNT I (Infringement of U.S. Patent No. 6,677,358) l6. Novo Nordisk hereby realleges and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Express Scripts
Medtronic
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.